InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
1
T+90 hit rate
50%
T+90 mean return
-5.5%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by COUGHLIN TIMOTHY, Director. Officer active across 4 companies, notably Travere Therapeutics, Inc.. In total, 16 filings have been logged. Split: 1 buy · 1 sell. Total volume traded: €111k. Activity tracked since 14 May 2021. The latest transaction was disclosed on 1 June 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations16 total
45,000 shares0Common SharesSEC:0001628280-26-040487:0
12,600 shares@ US$3.08100.0% of flowCommon SharesSEC:0001628280-26-040487:1
4,000 shares0Common StockSEC:0001376043-26-000006:0
6,500 shares0Common StockSEC:0001415889-25-013498:0
50,000 shares@ US$1.75100.0% of flowCommon StockSEC:0000950170-24-067989:0
Ideal exit: 24 Feb 2025 (T+270)
6,500 shares0Common StockSEC:0001415889-24-012846:0
6,000 shares0Common StockSEC:0001209191-23-031008:0
4,500 shares0Common StockSEC:0001209191-23-030958:0
6,000 sharesCommon stockSEC:0001209191-23-026062:0
8,650 shares0Common StockSEC:0001209191-22-036343:0
1,439 shares@ US$22.810.015% mcap100.0% of flowCommon StockSEC:0001209191-22-034541:0
3,000 shares0Common StockSEC:0001209191-22-028690:0
2,681 shares0Common StockSEC:0000899243-21-022090:0
2,681 shares0Common StockSEC:0000899243-21-022090
3,000 shares0Common StockSEC:0001209191-21-033855
3,000 shares0Common StockSEC:0001209191-21-033855:0
16 of 16 declarations
About COUGHLIN TIMOTHY
Timothy Coughlin is a Director at Travere Therapeutics, Inc. and FATE THERAPEUTICS INC. He brings his expertise to the boards, contributing to strategic decision-making for these companies. His role is essential in guiding Travere Therapeutics, Inc. and FATE THERAPEUTICS INC. in their growth initiatives.
